Attached files

file filename
EX-99.1 - EX-99.1 - Flexion Therapeutics Incflxn-ex991_7.htm
8-K - 8-K - Flexion Therapeutics Incflxn-8k_20201013.htm

Slide 1

Commercial Metrics Overview October 13, 2020 Exhibit 99.2

Slide 2

Commercial Metrics Overview Preliminary ZILRETTA® net sales of ~$23.6 million in Q3 2020 4,072 accounts (of 5,400 targets) had purchased ZILRETTA, as of September 30, 2020; up from 3,858, as of June 30, 2020 3,153 accounts had re-ordered ZILRETTA (77% of accounts that had purchased), as of September 30, 2020; up from 2,983 accounts that had re-ordered ZILRETTA (77% of accounts that had purchased) as of June 30, 2020

Slide 3

ZILRETTA Net Sales Note: Flexion recognizes ZILRETTA sales upon receipt of product by specialty distributors and pharmacies. Quarterly since launch

Slide 4

Distribution of Accounts by ZILRETTA Purchases Note: Flexion primarily sells ZILRETTA to specialty distributors and a specialty pharmacy; accounts (physicians, clinics and certain medical centers or hospitals) then subsequently purchase ZILRETTA directly from these specialty distributors and specialty pharmacy Cumulative

Slide 5

Distribution of ZILRETTA Purchases by Accounts Cumulative

Slide 6

ZILRETTA Purchases by New and Existing Accounts Cumulative

Slide 7